First new drug for IBS
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
by Gary Finnegan – World Health Matters (Belgium) – Providing energy-dense food supplements to malnourished children in developing countries has limited effect on the weight of malnourished children,… read more.
by Maria Dalby – Donating a kidney in later life can have a positive effect on quality of life, according to the largest study to date on this… read more.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths.
The Brussels Declaration, published in the European Respiratory Journal in 2008 recognises the high prevalence of patients with poorly controlled asthma and calls for changes in asthma management… read more.
The combination also appears to be cost effective. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with… read more.
Pain caused by 2 different mechanisms Apply the ointment, light on, light off – that’s how easy it is to cure various forms of non-melanoma skin cancer. However,… read more.
by Zara Qadir – ESC Geoffrey Rose Lecture on Population Sciences. The recipient of the ‘ESC Geoffrey Rose Lecture on Population Sciences’ went to Rory Collins (pictured), who… read more.
by Bruce Sylvester – Revamped ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (STEMI) include issues of diagnosis and treatment before,… read more.
by Bruce Sylvester – Revamped ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (STEMI) include issues of diagnosis and treatment before,… read more.
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.